Mount Sinai Respiratory Institute Presents: Advances in Pulmonary Medicine 2025
Attend the latest conferences, webinars, and networking events
Related Articles
The Sepsis Chain of Survival: A Comprehensive Framework for … : Critical Care Medicine
ute medical conditions, including sepsis. The “Sepsis Chain of Survival” underscores the importance of early recognition, prompt emergency medical services activation, timely antimicrobial administration and…
Dynamic 11C–Para–Aminobenzoic Acid Positron Emission Tomography/Computed Tomography for Visualizing Pulmonary Mycobacteroides abscessus Infections
Rationale: Mycobacteroides abscessus infections affect immunocompromised patients and those with underlying pulmonary disease. Conventional imaging cannot distinguish M. abscessus infections from u…
Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial
Rationale: Evaluation of optimal dosing has generally been inadequate during tuberculosis (TB) drug development. Fluoroquinolones are central to TB treatment. Objective: To determine the dose…
COPD guideline-recommended care differs by sex, overall rates low in veterans
SAN FRANCISCO — More women vs. men veterans with COPD received spirometry and tobacco cessation interventions, but more men received correct maintenance inhaler therapy, according…
The Grand Roundup
We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated
Goals of Care Assessment during Hospitalization for Sepsis
Rationale: Sepsis is a common cause of hospital mortality, as well as new morbidity among survivors. Clinical practice guidelines recommend assessing goals of care (GoCs)…
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
Numerous chronic human disorders are associated with immune activation by an obscure antigen (or antigens). We identified ChainA, a novel sarcoidosis epitope, by immunoscreening of…
From Repurposing to Refinement: Optimizing Levofloxacin for Treatment of Multidrug-Resistant Tuberculosis
After the development of rifampicin in 1963, nearly 50 years passed before the U.S. Food and Drug Administration approved a new antituberculosis drug, bedaquiline, in…
Individual market insurers requesting largest premium increases in more than 5 years – Peterson-KFF Health System Tracker
Early indications are that individual market insurers will be increasing premiums in 2026 by more than they have since 2018, the last time policy uncertainty…
Geographic Clusters in Sepsis Hospital Mortality and the… : Critical Care Medicine
low-performing hospitals to higher-performing hospitals within a cluster will improve sepsis outcomes. Design, Setting, and Patients: We conducted a cohort study of age-qualifying Medicare beneficiaries…